Mannatech (NASDAQ:MTEX) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued to investors on Tuesday. The firm issued a buy rating on the stock.

Mannatech Price Performance

Shares of MTEX opened at $9.80 on Tuesday. The company has a market cap of $18.47 million, a price-to-earnings ratio of -12.10 and a beta of 1.06. Mannatech has a 1-year low of $6.75 and a 1-year high of $16.49. The company’s fifty day simple moving average is $11.53 and its 200 day simple moving average is $9.99. The company has a current ratio of 1.25, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.